Special report: C-reactive protein for risk stratification in coronary heart disease screening.

Special report: C-reactive protein for risk stratification in coronary heart disease screening. [electronic resource] - TEC bulletin Nov 2002 - 31-7 p. digital

Publication Type: Journal Article

1543-1622


Biomarkers--analysis
Blue Cross Blue Shield Insurance Plans
C-Reactive Protein--metabolism
Cardiovascular Diseases--diagnosis
Drug Approval
Evidence-Based Medicine
Humans
Insurance Coverage
Outcome Assessment, Health Care
Predictive Value of Tests
Risk Assessment
Technology Assessment, Biomedical
United States
United States Food and Drug Administration